PMID- 27547425 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20160822 LR - 20210112 IS - 2053-3624 (Print) IS - 2053-3624 (Electronic) IS - 2053-3624 (Linking) VI - 3 IP - 2 DP - 2016 TI - Echo-Doppler determinants of outcomes in patients with unoperated significant mitral regurgitation in current era. PG - e000378 LID - 10.1136/openhrt-2015-000378 [doi] LID - e000378 AB - OBJECTIVE: One-half of patients with severe symptomatic mitral regurgitation (MR) do not undergo surgery due to comorbidities. We evaluated prognosticators of outcomes in patients with unoperated significant MR. METHODS: In this observational study, we retrospectively evaluated medical records of 75 consecutive patients with unoperated significant MR. RESULTS: All-cause mortality was 39% at 5 years. Non-survivors (n=29) versus survivors (n=46) were: older (77+/-9.8 vs 68+/-14, p=0.006), had higher New York Heart Association (NYHA) class (2.7+/-0.8 vs 2.3+/-0.8, p=0.037), higher brain natriuretic peptide (1157+/-717 vs 427+/-502 pg/mL, p=0.024, n=18), more coronary artery disease (61% vs 35%, p=0.031), more frequent left ventricular ejection fraction <50% (20.7% vs 4.3%, p=0.026), more functional MR (41% vs 22%, p=0.069), higher mitral E/E(') (12.7+/-4.6 vs 9.8+/-4, p=0.008), higher pulmonary artery systolic pressure (PASP; 52.6+/-18.7 vs 36.7+/-14, p <0.001), more >/=3+ tricuspid regurgitation (28% vs 4%, p=0.005) and more right ventricular dysfunction (26% vs 6%, p=0.035). Significant predictors of 5-year mortality were PASP (p=0.001) and E/E(') (p=0.011) using multivariate regression analysis. CONCLUSIONS: Patients with unoperated significant MR have high mortality. Elevated PASP and mitral E/E(') were the most significant predictors of 5-year survival in patients with unoperated significant MR. Current American College of Cardiology (ACC)/American Heart Association (AHA) guidelines provide a limited incorporation of echo-Doppler parameters in the preoperative risk stratification of patients with severe MR. FAU - Rafique, Asim M AU - Rafique AM AD - UCLA Medical Center , Los Angeles, California , USA. FAU - Zarrini, Parham AU - Zarrini P AD - Cedars-Sinai Heart Institute , Los Angeles, California , USA. FAU - Singh, Nirmal AU - Singh N AD - University of Arizona , Tucson, Arizona , USA. FAU - Beigel, Roy AU - Beigel R AD - Sheba-Tel Hashomer Hospital , Ramat Gan , Israel. FAU - Tadwalkar, Rigved AU - Tadwalkar R AD - UCLA Medical Center , Los Angeles, California , USA. FAU - Chonde, Meshe AU - Chonde M AD - UPMC Presbyterian , Pittsburgh, Pennsylvania , USA. FAU - Slipczuk, Leandro AU - Slipczuk L AD - Cedars-Sinai Heart Institute , Los Angeles, California , USA. FAU - Cercek, Bojan AU - Cercek B AD - Cedars-Sinai Heart Institute , Los Angeles, California , USA. FAU - Kar, Saibal AU - Kar S AD - Cedars-Sinai Heart Institute , Los Angeles, California , USA. FAU - Siegel, Robert J AU - Siegel RJ AD - Cedars-Sinai Heart Institute , Los Angeles, California , USA. LA - eng PT - Journal Article DEP - 20160801 PL - England TA - Open Heart JT - Open heart JID - 101631219 PMC - PMC4975870 OTO - NOTNLM OT - HEART FAILURE EDAT- 2016/08/23 06:00 MHDA- 2016/08/23 06:01 PMCR- 2016/08/01 CRDT- 2016/08/23 06:00 PHST- 2015/11/28 00:00 [received] PHST- 2016/04/19 00:00 [revised] PHST- 2016/06/07 00:00 [accepted] PHST- 2016/08/23 06:00 [entrez] PHST- 2016/08/23 06:00 [pubmed] PHST- 2016/08/23 06:01 [medline] PHST- 2016/08/01 00:00 [pmc-release] AID - openhrt-2015-000378 [pii] AID - 10.1136/openhrt-2015-000378 [doi] PST - epublish SO - Open Heart. 2016 Aug 1;3(2):e000378. doi: 10.1136/openhrt-2015-000378. eCollection 2016.